Akebia Therapeutics shares owned by Group One Trading
Quarter-by-quarter ownership of Akebia Therapeutics shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $203k | 154k | 1.32 |
| 2024-06-30 | $160k | 157k | 1.02 |
| 2024-03-31 | $247k | 135k | 1.83 |
| 2023-09-30 | $43k | 38k | 1.14 |
| 2023-06-30 | $53k | 58k | 0.92 |
| 2023-03-31 | $27k | 48k | 0.56 |
| 2022-12-31 | $15k | 25k | 0.58 |
| 2022-09-30 | $13k | 42k | 0.31 |
| 2022-06-30 | $19k | 54k | 0.35 |
| 2022-03-31 | $165k | 230k | 0.72 |
| 2021-12-31 | $51k | 23k | 2.26 |
| 2021-09-30 | $237k | 82k | 2.88 |
| 2021-06-30 | $498k | 131k | 3.79 |
| 2021-03-31 | $374k | 111k | 3.38 |
| 2020-12-31 | $13k | 4.5k | 2.89 |
| 2020-09-30 | $69k | 27k | 2.53 |
| 2020-06-30 | $490k | 36k | 13.57 |
| 2020-03-31 | $28k | 3.7k | 7.57 |
| 2019-12-31 | $70k | 11k | 6.31 |
| 2019-09-30 | $76k | 19k | 3.94 |
| 2019-06-30 | $85k | 18k | 4.83 |
| 2019-03-31 | $54k | 6.6k | 8.18 |
| 2018-12-31 | $201k | 36k | 5.54 |
| 2018-09-30 | $66k | 7.5k | 8.80 |
| 2018-06-30 | $169k | 17k | 10.00 |
| 2018-03-31 | $116k | 12k | 9.51 |
| 2017-12-31 | $180k | 12k | 14.88 |
| 2017-09-30 | $118k | 6.0k | 19.67 |
| 2017-06-30 | $573k | 40k | 14.36 |
| 2017-03-31 | $182k | 20k | 9.19 |
| 2016-12-31 | $278k | 27k | 10.41 |
| 2016-09-30 | $545k | 60k | 9.05 |
| 2016-06-30 | $325k | 43k | 7.49 |
| 2016-03-31 | $467k | 52k | 9.02 |
| 2015-12-31 | $78k | 6.0k | 13.00 |
| 2015-09-30 | $487k | 50k | 9.66 |
| 2015-06-30 | $207k | 20k | 10.30 |
| 2015-03-31 | $59k | 5.3k | 11.13 |
| 2014-12-31 | $107k | 9.2k | 11.63 |
| 2014-09-30 | $133k | 6.0k | 22.17 |
Top funds holding Akebia Therapeutics
View all funds holding Akebia Therapeutics